We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Find out what unacceptable or unreasonable actions are and how we approach them.
The MHRA is providing an update on the issue of increased intraocular pressure in patients implanted with EyeCee One preloaded and EyeCee One Crystal preloaded intraocular lenses.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Form A53: Application for a Contact Order (Section 26 Adoption and Children Act 2002 or an order for contact or prohibiting contact under section 51A of the Adoption and Children Act 2002).
How to get VAT relief if you’re buying goods because of your disability.
Submission dates and how the submissions using the EC decision reliance procedure work.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How to use an interrupted time series to evaluate your digital health product.
The characteristics, diagnosis and management of Candida auris (C. auris).
Services and care available through the NHS for adults.
How the government monitors imports into the UK.
Check the tariff classification for articles made of cermet.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.